A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
Part of paid clinical trials in Aurora, Colorado.
- Sponsor
- Bristol-Myers Squibb
- Study ID
- NCT07412704
- Phase
- PHASE1/PHASE2
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- BMS-986528 — DRUGSpecified dose on specified days
Study Details
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and the preliminary evidence of disease-modifying effect of BMS-986528 in participants with refractory, difficult-to-treat rheumatoid arthritis (RA).
Key Dates
- Start date
- May 28, 2026
- Status verified
- Feb 2026
- Primary completion
- Oct 30, 2029
- Completion
- Sep 2, 2030
Study Design
- Enrollment
- 84 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- SEQUENTIAL
- Primary purpose
- TREATMENT
Arms
- Experimental: Cohort A1
- Experimental: Cohort A2
- Experimental: Cohort A3
- Experimental: Cohort A4
- Experimental: Cohort A5
- Experimental: Cohort A6
- Experimental: Cohort A7
- Experimental: Cohort A8
- Experimental: Cohort B1
- Experimental: Cohort B2
Primary Outcome Measure
Number of participants with treatment-emergent adverse events (TEAEs) [ Time Frame: Up to Week 54 ]
Central Contacts
- BMS Clinical Trials Contact Center www.BMSClinicalTrials.com855-907-3286
- First line of the email MUST contain NCT # and Site #.
Locations (5)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Local Institution - 0050 | Aurora | Colorado | 80045 | Site 0050 |
| Local Institution - 0055 | South Miami | Florida | 33143 | Site 0055 |
| Local Institution - 0066 | Portland | Oregon | 97239 | Site 0066 |
| Local Institution - 0051 | DeSoto | Texas | 75115 | - |
| Local Institution - 0057 | San Antonio | Texas | 78229 | Site 0057 |
Find similar trials in Aurora, CO
By condition
Related Studies
- R-2487 in Patients With Rheumatoid ArthritisPHASE1 · Recruiting · Rise Therapeutics LLC · San Diego, California
- A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)PHASE2 · Recruiting · Merck Sharp & Dohme LLC · Glendale, Arizona
- Laser-based Photoacoustic Tomography of Human Inflammatory ArthritisRecruiting · University of Michigan · Ann Arbor, Michigan
- IMPACT - AndHealth Autoimmune Research RegistryRecruiting · AndHealth · Columbus, Ohio